Laboratorios Farmaceuticos Rovi (ROVIN) Q2 2020 Earnings Report
MX:ROVIN Q2 2020 EPS Results
- Actual EPS
- MXN 5.88
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- MXN 3.53
MX:ROVIN Q2 2020 Revenue Results
- Actual Revenue
- MXN 1.87B
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- -5.47%
Earnings Announcement Details
- Quarter
- Q2 2020
- Date
- 07/27/2020
- Time
- Before Open
- Conference Call
- Monday, July 27, 2020
MX:ROVIN Upcoming Earnings
Laboratorios Farmaceuticos Rovi's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q2 2020 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2020 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2020 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:ROVIN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | ―- | 23.56 | ― | ― |
| Jul 23, 2026 | 2026 (Q2) | ―30.45 | 8.79 | 246.57% (+21.67) | |
| May 06, 2026 | 2026 (Q1) | ―3.84 | 7.35 | -47.74% (-3.51) | |
| Feb 25, 2026 | 2025 (Q4) | ―17.32 | 9.49 | 82.49% (+7.83) | |
| Nov 06, 2025 | 2025 (Q3) | ―23.56 | 17.86 | 31.86% (+5.69) | |
| Jul 24, 2025 | 2025 (Q2) | ―8.79 | 17.86 | -50.81% (-9.08) | |
| May 08, 2025 | 2025 (Q1) | ―7.35 | 6 | 22.49% (+1.35) | |
| Feb 25, 2025 | 2024 (Q4) | ―9.49 | 20.65 | -54.02% (-11.15) | |
| Nov 07, 2024 | 2024 (Q3) | ―28.33 | 20.32 | 39.47% (+8.02) | |
| Jul 31, 2024 | 2024 (Q2) | ―17.86 | 7.48 | 138.89% (+10.39) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
